4//SEC Filing
Saks Samuel R 4
Accession 0001209191-18-034472
CIK 0001377121other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:29 PM ET
Size
5.6 KB
Accession
0001209191-18-034472
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2018-05-31+50,000→ 50,000 totalExercise: $7.28Exp: 2028-05-30→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of May 21, 2018, and 1/36th of the remaining shares subject to the option vesting each month.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001365615
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 6:29 PM ET
- Size
- 5.6 KB